Progyny, Inc.

PGNY Healthcare Healthcare Plans

Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.

Revenue
+8.91%
EPS
+115.3%
Free cash flow
+2.72%

Quarter to September 2026, against a year earlier

34.84 0.47 +1.37%
Market cap
$2.6B
P/E
30.1×
Fwd P/E
26.4×
Dividend yield
—
F-score
8/9
Altman Z
8.89
Beneish M
−3.45
Dividend safety
n/a

Progyny, Inc. (PGNY) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Progyny, Inc. (PGNY) trades at a P/E ratio of 30.1×. Over the past ten years it has ranged from 0.0× (September 2020) to 1,567× (December 2020); the current reading is higher than 26% of that period. That is above the Healthcare Plans industry median of 22.5× and above the Healthcare sector median of 24.5×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 37.2× 29.45%
FY2024 28.8× (49.01%)
FY2023 56.4× (39.18%)
FY2022 92.7× 36.24%
FY2021 68.0× (12.12%)
FY2020 77.4× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 21.8× (26.58%)
Jun 2026 29.7× 41.78%
Mar 2026 21.0× (43.67%)
Dec 2025 37.2× 14.14%
28 more quarters

Against its own ten years

Low 0.0× High 1,567×
Ten-year median 48.1×
Current reading's percentile 14

P/E ratio against peers

Company P/E ratio
CLOV Clover Health Investments, Corp. compare n/m
MOH Molina Healthcare, Inc compare n/m
OSCR Oscar Health, Inc. compare 11.0×
CI Cigna Group compare 12.9×
ELV Elevance Health, Inc. compare 18.2×
CNC Centene Corporation compare 23.5×
PGNY Progyny, Inc. 30.1×
HUM Humana Inc. compare 41.9×
ALHC Alignment Healthcare, Inc. compare 48.4×
Healthcare Plans industry median 22.5×
Healthcare sector median 24.5×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PGNY